Shizuoka
Recruiting
Healthy Volunteers
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase
3Span
238 weeksSponsor
Ono Pharmaceutical Co. LtdShizuoka
Recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Phase
1Span
276 weeksSponsor
Eli Lilly and CompanyShizuoka
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors
Phase
1Span
157 weeksSponsor
GlaxoSmithKlineShizuoka
Recruiting
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
Phase
2Span
83 weeksSponsor
Ono Pharmaceutical Co. LtdShizuoka
Recruiting
A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)
Phase
3Span
377 weeksSponsor
IpsenShizuoka
Recruiting
Shizuoka
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Phase
3Span
278 weeksSponsor
GlaxoSmithKlineShizuoka
Recruiting
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Phase
2Span
95 weeksSponsor
Eli Lilly and CompanyShizuoka
Recruiting
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Phase
3Span
115 weeksSponsor
Novo Nordisk A/SShizuoka
Recruiting
1-10 of 59